No results for ‘’
Remedium Lifecare Ltd
₹0.26
(3.70%)
Sat, 19 Sept 2026, 02:10 pm
Consumer Durables
Motor Vehicles
24.5KRemedium Lifecare EV/EBITDA Ratio
| Particulars | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Price to earnings ratio | 33.04 | 46.16 | 48.95 | 33.42 | 34.43 |
| Price to book ratio | 4.11 | 10.10 | 25.62 | 25.46 | 1.67 |
| Price to sales ratio | 0.18 | 0.10 | 0.52 | 0.27 | 0.18 |
| Price to cash flow ratio | 0 | 4.46 | 12.98 | 0 | 0 |
| Enterprise value | 25.53Cr | 48.42Cr | 244Cr | 1148Cr | 1211Cr |
| Enterprise value to EBITDA ratio | 35.82 | 57.95 | 33.86 | 33.57 | 0 |
| Debt to equity ratio | 2.72 | 0 | 0 | 1.34 | 26.01 |
| Return on equity % | 0 | 24.51 | 70.92 | 122.76 | 4.90 |
Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio
The Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio is a key financial metric used by investors to evaluate Remedium Lifecare Ltd's valuation, profitability, and overall financial performance. Tracking the Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Remedium Lifecare Ltd (NSE: , BSE: 539561) is currently trading at ₹0.26, with a market capitalization of ₹23.81Cr. As a leading company in the Consumer durables sector and Motor vehicles industry, monitoring the Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio is essential for fundamental analysis.
Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio Current Value
The current Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio stands at 0.
The Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio Historical Trend
The Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio has shown the following historical trend:
- 2024: 0
- 2023: 33.57
- 2022: 33.86
- 2021: 57.95
- 2020: 35.82
The decline in Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio indicates improving financial efficiency or better earnings growth.
What Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio Indicates for Investors
The Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Remedium Lifecare Ltd.
Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio Analysis Summary
The Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Remedium Lifecare Ltd Enterprise Value to EBITDA Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.